Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Clinical Study of Venetoclax Combined With Azactidine in the Treatment of Acute Leukaemias of Ambiguous Lineage

NCT05901974 is registered in ClinicalTrials.gov with Sheng-Li Xue, MD as lead sponsor.

NCT NCT05901974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05901974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Clinical Study of Venetoclax Combined With Azactidine in the Treatment of Acute Leukaemias of Ambiguous Lineage
Lead sponsor
Sheng-Li Xue, MD
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2023
Completion date
March 1, 2026
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia of ambiguous lineage